Susan B. Meister Child Health Evaluation and Research Center, National Clinician Scholars Program, Institute for Healthcare Policy and Innovation, Department of Pediatrics, University of Michigan, Ann Arbor.
Department of Family Medicine, University of Michigan, Ann Arbor.
JAMA Netw Open. 2022 Jun 1;5(6):e2216628. doi: 10.1001/jamanetworkopen.2022.16628.
Vaccine incentives have been used across the US to encourage COVID-19 vaccine uptake and include programs targeted to adolescents and young adults. However, little is known about youths' views regarding these initiatives.
To assess experiences and perceptions of COVID-19 vaccine incentives in a nationwide sample of US youth.
DESIGN, SETTING, AND PARTICIPANTS: A qualitative survey study was conducted using the MyVoice text message-based polling platform from October 22 to October 29, 2021. Participants were US adolescents and young adults aged 14 to 24 years, who were sent 5 open-ended questions to assess their experiences and perceptions of COVID-19 vaccine incentives. Qualitative responses were analyzed thematically. Descriptive statistical analysis was performed in January 2022.
Experiences, perceptions, and opinions related to COVID-19 vaccine incentives as measured by survey response.
A total of 1125 of 1206 youth (93%) responded to the survey and had a mean (SD) age of 20 (2) years, 664 (59%) identified as male, and 769 (68%) identified as non-Hispanic White. Of respondents, 871 (79%) reported having heard of vaccine incentives, and 892 (82%) believed they were a good idea or had positive attributes. Notably, 305 youth (28%) expressed concerns about vaccine incentives, citing uncertainty about their effectiveness (86 [28%]), their ethical use (63 [21%]), the impact on vaccine motivations (51 [17%]), and confidence (39 [13%]), and lack of fairness (35 [11%]). Only 73 youth (7%) reported that an incentive influenced their decision to get a COVID-19 vaccine. When asked what they thought would motivate others to get a COVID-19 vaccine, youth with an opinion (536 of 1032 [52%]) most commonly reported incentives (112 [21%]) and additional COVID-19 vaccine testing, safety, or regulation (115 [21%]).
COVID-19 vaccine incentives are well known to youth but not a significant self-reported motivator for vaccination. Although generally viewed favorably, more than a quarter of youth expressed concerns regarding vaccine incentives, including but not limited to their ethics, effectiveness, fairness, and impacts on vaccine motivation and confidence. Policymakers considering targeted use of COVID-19 vaccine incentives should weigh youths' perspectives on these initiatives alongside objective effectiveness and cost-effectiveness data.
在美国，疫苗激励措施已被用于鼓励 COVID-19 疫苗接种，包括针对青少年和年轻人的计划。然而，对于年轻人对这些举措的看法知之甚少。
在全国性的美国青年样本中评估 COVID-19 疫苗激励措施的经验和看法。
设计、设置和参与者： 2021 年 10 月 22 日至 10 月 29 日，使用 MyVoice 文本消息投票平台进行了一项定性调查研究。参与者为年龄在 14 至 24 岁之间的美国青少年和年轻人，他们收到了 5 个开放式问题，以评估他们对 COVID-19 疫苗激励措施的经验和看法。定性回应是根据主题进行分析的。在 2022 年 1 月进行了描述性统计分析。
通过调查回应衡量与 COVID-19 疫苗激励措施相关的经验、看法和意见。
共有 1206 名青年中的 1125 名（93%）对调查做出了回应，平均（SD）年龄为 20（2）岁，664 名（59%）为男性，769 名（68%）为非西班牙裔白人。在回答者中，871 名（79%）报告听说过疫苗激励措施，892 名（82%）认为这是一个好主意或具有积极属性。值得注意的是，305 名青年（28%）对疫苗激励措施表示担忧，他们对激励措施的有效性（86 [28%]）、其道德用途（63 [21%]）、对疫苗接种动机的影响（51 [17%]）、信心（39 [13%]）和公平性（35 [11%]）表示不确定。只有 73 名青年（7%）报告说激励措施影响了他们接种 COVID-19 疫苗的决定。当被问及他们认为什么会促使其他人接种 COVID-19 疫苗时，有意见的青年（1032 名中的 536 名[52%]）最常报告激励措施（112 名[21%]）和额外的 COVID-19 疫苗测试、安全性或监管（115 名[21%]）。
COVID-19 疫苗激励措施广为人知，但不是年轻人自我报告接种疫苗的主要动机。尽管总体上受到好评，但超过四分之一的年轻人对疫苗激励措施表示担忧，包括但不限于其道德、有效性、公平性以及对疫苗接种动机和信心的影响。考虑有针对性地使用 COVID-19 疫苗激励措施的政策制定者应权衡年轻人对这些举措的看法，同时考虑到客观的有效性和成本效益数据。
